WallStreetZenWallStreetZen

NASDAQ: KYNB
Kyntra Bio Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for KYNB

Based on 1 analyst offering 12 month price targets for Kyntra Bio Inc

Min Forecast
$43.00+366.38%
Avg Forecast
$43.00+366.38%
Max Forecast
$43.00+366.38%

Should I buy or sell KYNB stock?

Based on 1 analyst offering ratings for Kyntra Bio Inc.

Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although KYNB's forecast from analysts indicates a "Buy", our proven Zen Rating quant model rates KYNB as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their KYNB stock forecasts and price targets.

KYNB stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-09-24

1 of 1

Forecast return on equity

Is KYNB forecast to generate an efficient return?

Forecast return on assets

Is KYNB forecast to generate an efficient return on assets?

Company
-20.81%
Industry
95.87%
KYNB is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

KYNB earnings per share forecast

What is KYNB's earnings per share in the next 3 years based on estimates from 4 analysts?

Avg 1 year Forecast
-$12.19-122.79%
Avg 2 year Forecast
-$10.87-120.32%
Avg 3 year Forecast
-$7.05-113.18%

KYNB revenue forecast

What is KYNB's revenue in the next 3 years based on estimates from 4 analysts?

Avg 1 year Forecast
$6.2M
Avg 2 year Forecast
$6.2M
Avg 3 year Forecast
$6.3M

KYNB vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
KYNB$9.22$43.00+366.38%Buy
XCUR$5.84N/AN/A
GBIO$5.48$8.88+61.95%Buy
CELU$1.30$6.00+361.54%Buy
OTLK$0.59$3.83+549.66%Hold
View Top Biotech Stocks

Kyntra Bio Stock Forecast FAQ

Is Kyntra Bio Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: KYNB) stock is to Buy KYNB stock.

Out of 1 analyst, 0 (0%) are recommending KYNB as a Strong Buy, 1 (100%) are recommending KYNB as a Buy, 0 (0%) are recommending KYNB as a Hold, 0 (0%) are recommending KYNB as a Sell, and 0 (0%) are recommending KYNB as a Strong Sell.

If you're new to stock investing, here's how to buy Kyntra Bio stock.

What is KYNB's earnings growth forecast for 2026-2028?

(NASDAQ: KYNB) Kyntra Bio's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 137.65%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 104.96%.

Kyntra Bio's earnings in 2026 is $215,654,000.On average, 4 Wall Street analysts forecast KYNB's earnings for 2026 to be -$49,309,929, with the lowest KYNB earnings forecast at -$68,943,283, and the highest KYNB earnings forecast at -$27,652,639. On average, 4 Wall Street analysts forecast KYNB's earnings for 2027 to be -$43,966,301, with the lowest KYNB earnings forecast at -$58,080,454, and the highest KYNB earnings forecast at -$28,289,797.

In 2028, KYNB is forecast to generate -$28,513,105 in earnings, with the lowest earnings forecast at -$27,394,944 and the highest earnings forecast at -$29,351,726.

What is KYNB's revenue growth forecast for 2026-2028?

(NASDAQ: KYNB) Kyntra Bio's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 307.61%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 55.82%.

Kyntra Bio's revenue in 2026 is -$118,093,000.On average, 4 Wall Street analysts forecast KYNB's revenue for 2026 to be $25,251,668, with the lowest KYNB revenue forecast at $23,944,989, and the highest KYNB revenue forecast at $26,335,847. On average, 4 Wall Street analysts forecast KYNB's revenue for 2027 to be $25,251,668, with the lowest KYNB revenue forecast at $23,944,989, and the highest KYNB revenue forecast at $26,335,847.

In 2028, KYNB is forecast to generate $25,583,394 in revenue, with the lowest revenue forecast at $24,580,124 and the highest revenue forecast at $26,335,847.

What is KYNB's forecast return on assets (ROA) for 2026-2028?

(NASDAQ: KYNB) forecast ROA is -20.81%, which is lower than the forecast US Biotechnology industry average of 95.87%.

What is KYNB's Price Target?

According to 1 Wall Street analyst that have issued a 1 year KYNB price target, the average KYNB price target is $43.00, with the highest KYNB stock price forecast at $43.00 and the lowest KYNB stock price forecast at $43.00.

The Wall Street analyst predicted that Kyntra Bio's share price could reach $43.00 by Sep 24, 2026. The average Kyntra Bio stock price prediction forecasts a potential upside of 366.38% from the current KYNB share price of $9.22.

What is KYNB's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: KYNB) Kyntra Bio's current Earnings Per Share (EPS) is $53.48. On average, analysts forecast that KYNB's EPS will be -$12.19 for 2026, with the lowest EPS forecast at -$17.04, and the highest EPS forecast at -$6.84. On average, analysts forecast that KYNB's EPS will be -$10.87 for 2027, with the lowest EPS forecast at -$14.36, and the highest EPS forecast at -$6.99. In 2028, KYNB's EPS is forecast to hit -$7.05 (min: -$6.77, max: -$7.26).

What is KYNB's forecast return on equity (ROE) for 2026-2028?

(NASDAQ: KYNB) forecast ROE is N/A, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.